Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

No Sign Of Capital Equipment Turn-Around In Philips’ Q1 Sales

This article was originally published in The Gray Sheet

Executive Summary

Declining sales of imaging and patient monitoring systems were a significant drag on Philips' health care business in the first quarter of 2009, the firm reported April 14

You may also be interested in...



Volcano Defies Downward Trend In Imaging Market With 24% Q1 Sales Growth

Despite a scarcity of capital available to hospitals to buy imaging equipment, Volcano placed 74% more intravascular ultrasound (IVUS) consoles in the first quarter of 2009 than it did in the same quarter a year ago, the company reported May 7

Philips Grows Image-Guided Interventional Offerings With Traxtal Acquisition

Philips is augmenting its imaging business with the acquisition of Toronto-based Traxtal, manufacturer of the PercuNav computer-assisted, image-guided soft tissue navigation system

Volcano Defies Downward Trend In Imaging Market With 24% Q1 Sales Growth

Despite a scarcity of capital available to hospitals to buy imaging equipment, Volcano placed 74% more intravascular ultrasound (IVUS) consoles in the first quarter of 2009 than it did in the same quarter a year ago, the company reported May 7

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027351

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel